De Novo
DEN120012: CDC DENV-1-4 REAL TIME RT-PCT ASSAY
FDA De Novo · centers for disease control and prevention · decided May 24, 2012
Key facts
| De Novo number | DEN120012 |
|---|---|
| Device name | CDC DENV-1-4 REAL TIME RT-PCT ASSAY |
| Applicant | centers for disease control and prevention |
| Product code | OZB |
| Date received | Mar 12, 2012 |
| Decision date | May 24, 2012 |
| Decision | granted (DENG) |
| FDA classification | Class II |
| Review panel | Microbiology |
| FEI number | 1050190 |
At a glance
- None Later 510(k)s citing this De Novo
- None UDI device identifiers (GUDID)
- None MAUDE adverse event reports
- None Recall events
- No Decision summary on file
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About De Novo classification requests
The De Novo pathway classifies novel low- to moderate-risk devices that have no legally marketed predicate; each granted request creates a new classification regulation and product code.
Source: U.S. Food and Drug Administration (FDA), De Novo database · Source date: